Editorial policy | Eurasian Journal of Applied Biotechnology

Eurasian Journal of Applied Biotechnology (eISSN 2617-1147) is an international peer-reviewed open access journal publishes original fundamental and applied research, letters, review and hypothesis articles in all key areas of modern biotechnology, medical genetics and genomics, and ecological research.

The publication is intended to both scientific and technical professionals as well as wide range of intellectual readers that are eager to be aware of the recent achievements of worldwide biotechnology.

The journal has been published by National Center for Biotechnology since 1996.

Open Access free for readers, with article processing charges (APC) paid by authors or their institutions.

The journal has a designed and approved cover and title pages, issue imprint, eISSN, editorial staff, editorial policy, publication ethics and website.

Journal articles are registered in the CrossRef database, and each author's article must be assigned a DOI - a digital object identifier, which is used to provide citations, links and access to electronic documents.

The journal is indexed by the Kazakhstan Citation Base JSC "National Center of Science and Technology Evaluation" (NCSTE).

The journal is placed in the elibrary.ru Scientific Electronic Library in open access for readers and is included in the analytical database "Russian Science Citation Index" (RSCI).

The journal follows the policy of information openness and accessibility of authors' publications; articles are posted on the journal's website in three languages in full-text access.

Eurasian Journal of Applied Biotechnology uses double-blind review, which means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process. Before being sent to reviewers, manuscripts are pre-screened by the editorial office to check that they agree with the criteria for publishing in Eurasian Journal of Applied Biotechnology: accordance with the aims and scope of the journal, nature of the study, originality of the results, quantity and quality of data, general conclusions, and presentation of the work with a good quality of language. If the paper does not fulfill these criteria, it may be rejected at this stage without review.

Aims and Scope

Eurasian Journal of Applied Biotechnology is fully comprehensive in its scope and publishes strictly peer-reviewed papers, protocols and methods, notes to the editor, letters to the editor and reviews covering novel aspects and methods in all areas of biotechnology, medical and ecological research. The publication is intended to both scientific and technical professionals as well as wide range of intellectual readers that are eager to be aware of the recent achievements of worldwide biotechnology. Some issues are devoted to a special topic, providing the latest information on the most crucial areas of research and technological advances.

In addition to these special issues, the journal welcomes unsolicited submissions for primary research articles, such as Research Articles, Rapid Communications and Biotechnological Methods. Eurasian Journal of Applied Biotechnology also welcomes proposals of Review Articles. Prospective review authors should contact the Reviews Editor before submitting a manuscript.

Eurasian Journal of Applied Biotechnology promotes a special emphasis on:

General and Applied Biotechnology
Synthetic Biology and Bioinformatics
Nanobiotechnology and Biomaterials
Tissue engineering, Regenerative Medicine and Stem cells
Gene Editing, Gene therapy and Immunotherapy
Omics technologies
Industrial Biotechnology, Biopharmaceuticals and Biocatalysis
Bioprocess engineering and Downstream processing
Plant Biotechnology
Biosafety, Biotech Ethics, Science Communication
Methods and Advances

Currently 4 issues per year.

Release Schedule:

Issue No. 1 January – March

Issue No. 2 April – June

Issue No. 3 July – September

Issue No. 4 October – December

A working language of the journal is Kazakh, English and Russian.

Readership

Biotechnologists, Microbiologists, Engineers, Medical and pharmaceutical scientists, Food and nutrition scientists, Agriculturists, Environmental scientists.

Submit the Article or Review

The publication of materials in the journal is carried out using the Open Journal System, an online submission and review system. The editorial board accepts previously unpublished experimental articles in the scientific areas of the journal.

Manuscripts should be submitted Online click the make a new submission link from www.biotechlink.org. The use of an online submission and peer review site speeds up the decision-making process, enables immediate distribution, and allows authors to track the status of their own manuscripts.

If assistance is needed, Editorial Office can be contacted and will readily provide any help users need to upload their manuscripts.

Editorial Office contact: info@biotechlink.org

Peer Review Information

Selection of reviewers is the responsibility of the Editor, although the PhD scientists on staff make recommendations to the Editor from a database of individuals who have reviewed manuscripts previously. This database includes self-identified areas of expertise as well as information about the perceived usefulness and timeliness of past reviews. Individuals who consistently have provided tardy or unhelpful reviews are removed from the database. Every effort is made to avoid both real and apparent conflicts of interest with respect to research activities or collaborative or personal interactions. Reviewers are asked to with draw from considering any manuscript in which they identify a conflict that has escaped the attention of the Editor.

The journal uses double blind peer review, carried out by at least two scientists who have the degree of candidate of science, doctor of science, doctor of philosophy (PhD) and scientific specialization on the topic of the reviewed manuscript.

Information contained in manuscripts is considered confidential and should not be shared or distributed. If necessary, a reviewer can consult with others for an adequate evaluation of the research findings if all individuals involved maintain confidentiality, objectivity, and avoid conflict of interest. NCB is not responsible for acts and conduct by reviewers that are not in accordance with accepted professional standards. Reviewers are asked to be objective in their evaluations and to judge primarily the novelty and soundness of the information presented.

Although reviews are anonymous, all comments should be capable of withstanding public scrutiny. Except in very unusual circumstances, the identity of the reviewers and Editors involved in the review of any given manuscript is kept confidential.

Archiving and Availability

The journal has been published by National Center for Biotechnology since 1996.

Open Access free for readers, with article processing charges (APC) paid by authors or their institutions.

The journal has a designed and approved cover and title pages, issue imprint, eISSN, editorial staff, editorial policy, publication ethics and website.

The journal is indexed by the Kazakhstan Citation Base JSC "National Center of Science and Technology Evaluation" (NCSTE).

The journal is placed in the elibrary.ru Scientific Electronic Library in open access for readers and is included in the analytical database "Russian Science Citation Index" (RSCI).

The journal follows the policy of information openness and accessibility of authors' publications; articles are posted on the journal's website in three languages in full-text access.

Publishing Ethics

For information on Ethics in publishing and Ethical guidelines for journal publication see http://www.elsevier.com/publishingethics and http://www.elsevier.com/journal-authors/ethics.

Submission of an article to the “Eurasian Journal of Applied Biotechnology” implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see http://www.elsevier.com/postingpolicy), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. In particular, translations into English of papers already published in another language are not accepted.

No other forms of scientific misconduct are allowed, such as plagiarism, falsification, fraudulent data, incorrect interpretation of other works, incorrect citations, etc. The “Eurasian Journal of Applied Biotechnology” follows the Code of Conduct of the Committee on Publication Ethics (COPE), and follows the COPE Flowcharts for Resolving Cases of Suspected Misconduct (http://publicationethics.org/files/u2/New_Code.pdf). To verify originality, your article may be checked by the originality detection service CrossCheck http://www.elsevier.com/editors/plagdetect.

The authors are obliged to participate in peer review process and be ready to provide corrections, clarifications, retractions and apologies when needed. All authors of a paper should have significantly contributed to the research.

The reviewers should provide objective judgments and should point out relevant published works which are not yet cited. Reviewed articles should be treated confidentially. The reviewers will be chosen in such a way that there is no conflict of interests with respect to the research, the authors and/or the research funders.

The editors have complete responsibility and authority to reject or accept a paper, and they will only accept a paper when reasonably certain. They will preserve anonymity of reviewers and promote publication of corrections, clarifications, retractions and apologies when needed. The acceptance of a paper automatically implies the copyright transfer to the “Eurasian Journal of Applied Biotechnology”.